WHO classification-based Prognostic Scoring System (WPSS) of primary myelodysplastic syndromes.52
Variable . | 0 . | 1 . | 2 . | 3 . |
---|---|---|---|---|
* Good: normal, -Y, del(5q), del(20q); Poor: complex, chromosome 7 anomalies; Intermediate: other abnormalities | ||||
** Transfusion dependency: at least one transfusion every 8 weeks over a period of 4 months | ||||
Risk groups: very low (score 0), low (score 1), intermediate (score 2), high (score 3–4), very high (score 5–6). | ||||
WHO Category | RA, RARS, 5q- | RCMD, RCMD-RS | RAEB-1 | RAEB-2 |
Karyotype* | Good | Intermediate | Poor | — |
Transfusion requirement** | No | Regular | — | — |
Variable . | 0 . | 1 . | 2 . | 3 . |
---|---|---|---|---|
* Good: normal, -Y, del(5q), del(20q); Poor: complex, chromosome 7 anomalies; Intermediate: other abnormalities | ||||
** Transfusion dependency: at least one transfusion every 8 weeks over a period of 4 months | ||||
Risk groups: very low (score 0), low (score 1), intermediate (score 2), high (score 3–4), very high (score 5–6). | ||||
WHO Category | RA, RARS, 5q- | RCMD, RCMD-RS | RAEB-1 | RAEB-2 |
Karyotype* | Good | Intermediate | Poor | — |
Transfusion requirement** | No | Regular | — | — |